中文   |   English   |   Email Alert

Small Molecular Platinum(Ⅳ) Compounds as Antitumor Agents

Xiaoxiao Tan, Guoshuai Li, Qingpeng Wang, Bingquan Wang, Dacheng Li, Peng George Wang

Progress in Chemistry ›› 2018, Vol. 30 ›› Issue (6) : 831 -846.

PDF (2465KB)
Progress in Chemistry ›› 2018, Vol. 30 ›› Issue (6) : 831-846 DOI: 10.7536/PC171212
Scan to read & Share
Small Molecular Platinum(Ⅳ) Compounds as Antitumor Agents
Author information +
History +
PDF (2465KB)

Abstract

Platinum(Ⅳ) compounds which exert unique advantages as antitumor drugs,have aroused wide attention of researchers in pharmaceutical area. A great deal of efforts have been devoted to this field, and many remarkable results are achieved. The investigation on platinum(Ⅳ) compounds has become an active and hot topic. Large numbers of complexes with high activity, low toxicity, low drug-resistance, high bioavailability, satisfactory pharmacokinetic property and remarkable tumor targeting property have been prepared and evaluated in recent years. The current work is mainly focused on the following two aspects:(1) Platinum(Ⅳ) compounds based on classical platinum drugs. Various functional axial ligands are incorporated to platinum system to construct novel multi-functional platinum(Ⅳ) compounds with effective activities. (2) Platinum(Ⅳ) compounds based on non-classical platinum compounds are obtained by modifying the transverse ligands to prepare platinum(Ⅳ) complexes with non-classical platinum(Ⅱ) cores, and these target compounds have shown great competence in overcoming drug resistance of platinum drugs. Moreover, photosensitive platinum(Ⅳ) compounds have good performance in photodynamic therapy which is a new trend of clinical cancer treatment. Platinum(Ⅳ) compounds are of great potentials to be developed as the next generation of approved platinum anticancer drugs with oral administration. Herein, by combining authors' research and referring to the works from literatures in recent five years, the research progress of small molecular platinum(Ⅳ) compounds as antitumor agents is systematically reviewed, and the perspectives of the foreseeable future of platinum(Ⅳ) compounds as medicinal drugs are also presented.
Contents
1 Introduction
2 Platinum (Ⅳ) compounds based on classical platinum drugs
2.1 Lipid/water tuning
2.2 Membrane protein targeting
2.3 Energy metabolism enzyme targeting
2.4 Mitochondrial targeting
2.5 HSA targeting
2.6 Inflammatory factor targeting
2.7 DNA targeting
2.8 HDAC targeting
2.9 Others
3 Platinum (Ⅳ) compounds based on non-classical platinum compounds
3.1 Modification of stable ligands
3.2 Modification of leaving ligands
3.3 Photosensitive platinum (Ⅳ) compounds with azido ligands
4 Conclusion

Graphical abstract

Keywords

platinum drug / platinum (Ⅳ) / antitumor / prodrug / multi-targeting drug

Cite this article

Download citation ▾
Xiaoxiao Tan, Guoshuai Li, Qingpeng Wang, Bingquan Wang, Dacheng Li, Peng George Wang. Small Molecular Platinum(Ⅳ) Compounds as Antitumor Agents. Progress in Chemistry, 2018, 30(6): 831-846 DOI:10.7536/PC171212

登录浏览全文

4963

注册一个新账户 忘记密码

References

PDF (2465KB)

4598

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉